Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Alzamend Neuro, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +3 vs. Q2 2023
- Shares held
- 6.31M
- +159.0K (+2.6%) vs. Q2 2023
- Total value
- $1.49M
- −$1.64M (−52.3%) vs. Q2 2023
- New holders
- 6
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $3.26M |
| Q1 2026 | 13 | $723.1K |
| Q4 2025 | 13 | $447.2K |
| Q3 2025 | 11 | $351.3K |
| Q2 2025 | 7 | $6.36K |
| Q1 2025 | 11 | $59.9K |
| Q4 2024 | 17 | $131.7K |
| Q3 2024 | 12 | $71.2K |
| Q2 2024 | 16 | $150.5K |
| Q1 2024 | 13 | $386.8K |
| Q4 2023 | 16 | $334.7K |
| Q3 2023 | 27 | $1.49M |
| Q2 2023 | 24 | $3.13M |
| Q1 2023 | 26 | $2.64M |
| Q4 2022 | 33 | $3.98M |
| Q3 2022 | 17 | $9.41M |
| Q2 2022 | 21 | $2.70M |
| Q1 2022 | 22 | $4.01M |
| Q4 2021 | 20 | $1.66M |
| Q3 2021 | 17 | $1.99M |
| Q2 2021 | 11 | $2.58M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Alzamend Neuro, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 79 | $0 | 0.00% | −400−83.5% | Reduced |
| JPMorgan Chase & Co | 49 | $12 | 0.00% | +49 | New |
| FMR LLC | 268 | $64 | 0.00% | +268 | New |
| Wells Fargo & Company | 495 | $117 | 0.00% | +76+18.1% | Added |
| Morgan Stanley | 500 | $119 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,000 | $237 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 3,000 | $711 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 5,000 | $1.19K | 0.00% | −1,000−16.7% | Reduced |
| UBS Group AG | 7,927 | $1.88K | 0.00% | +7,668+2,960.6% | Added |
| Insight Wealth Strategies, LLC | 10,000 | $2.37K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 12,974 | $3.08K | 0.00% | +12,974 | New |
| Commonwealth Equity Services, LLC | 16,666 | $4.00K | 0.00% | 00.0% | Unchanged |
| Foundations Investment Advisors, LLC | 20,000 | $4.74K | 0.00% | +20,000 | New |
| Renaissance Technologies LLC | 21,400 | $5.00K | 0.00% | +21,400 | New |
| Millennium Management LLC | 27,629 | $6.55K | 0.00% | +27,629 | New |
| Two Sigma Securities, LLC | 28,156 | $6.67K | 0.00% | +5,516+24.4% | Added |
| State Street Corp | 31,900 | $7.56K | 0.00% | 00.0% | Unchanged |
| Integrated Investment Consultants, LLC | 40,000 | $9.48K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 40,367 | $9.57K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 48,605 | $11.5K | 0.00% | +31,385+182.3% | Added |
| Charles Schwab Investment Management Inc | 53,080 | $12.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 103,775 | $24.6K | 0.00% | 00.0% | Unchanged |
| RFG Advisory, LLC | 250,000 | $59.3K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 596,129 | $141.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 636,010 | $150.8K | 0.00% | +72,350+12.8% | Added |
| Vanguard Group Inc | 2,035,253 | $482.4K | 0.00% | −1,999−0.1% | Reduced |
| Truist Financial Corp | 2,314,907 | $548.6K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,309−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,503−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −5,062−100.0% | Sold out |